| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Section of Immunobiology, Yale University School of Medicine, New Haven, CT 06520
Most hemopoietic cells express one or more members of the Ly-6 supergene family of small glycosylphosphatidylinositol-linked proteins. Although levels of Ly-6 proteins vary with stages of differentiation and activation, their function largely remains unknown. To ascertain whether ligands for Ly-6 proteins exist, chimeric proteins were constructed in which Ly-6E, Ly-6C, and Ly-6I were fused to the murine IgM heavy chain. These chimeras specifically stained both developing and mature B lymphocytes, as assessed by flow cytometry. Analysis of variants of the CH27 B cell lymphoma revealed that Ly-6A/E and Ly-6I recognized different molecules. CH27 cells with low levels of Ly-6A/E ligand activity also lost expression of CD22, and cells transfected with CD22 gained the ability to bind the Ly-6A/E chimera and, to a lesser extent, the Ly-6C and Ly-6I chimeric proteins. As many mature B cells coexpress Ly-6A/E and CD22, the function of Ly-6 molecules may be to associate with other membrane proteins, possibly concentrating these ligands in lipid rafts, rather than acting directly as cell:cell adhesion molecules.
This article has been cited by other articles:
|
|
 |
|
  M. T. Ortega, M. J. Pecaut, D. S. Gridley, L. S. Stodieck, V. Ferguson, and S. K. Chapes Shifts in bone marrow cell phenotypes caused by spaceflight J Appl Physiol, February 1, 2009; 106(2): 548 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Tang, Y Gu, M Zhang, S Ye, X Chen, Q Guo, J Qian, C Bao, S Chen, and N Shen Increased expression of the type I interferon-inducible gene, lymphocyte antigen 6 complex locus E, in peripheral blood cells is predictive of lupus activity in a large cohort of Chinese lupus patients Lupus, September 1, 2008; 17(9): 805 - 813. [Abstract] [PDF]
|
|
|
|
 |
|
 A M Jacobi, D M Goldenberg, F Hiepe, A Radbruch, G R Burmester, and T Dorner Differential effects of epratuzumab on peripheral blood B cells of patients with systemic lupus erythematosus versus normal controls Ann Rheum Dis, April 1, 2008; 67(4): 450 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Flanagan, Z. Modrusan, J. Cornelius, A. Chavali, I. Kasman, L. Komuves, L. Mo, and L. Diehl Intestinal Epithelial Cell Up-Regulation of LY6 Molecules during Colitis Results in Enhanced Chemokine Secretion J. Immunol., March 15, 2008; 180(6): 3874 - 3881. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Holmes and W. L. Stanford Concise Review: Stem Cell Antigen-1: Expression, Function, and Enigma Stem Cells, June 1, 2007; 25(6): 1339 - 1347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Haas, S. Sen, I. G. Sanford, A. S. Miller, J. C. Poe, and T. F. Tedder CD22 Ligand Binding Regulates Normal and Malignant B Lymphocyte Survival In Vivo. J. Immunol., September 1, 2006; 177(5): 3063 - 3073. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
